Hillsdale Investment Management Inc. Raises Holdings in Cameco Corporation $CCJ

Hillsdale Investment Management Inc. increased its stake in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 42.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 241,383 shares of the basic materials company’s stock after buying an additional 71,935 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Cameco were worth $20,253,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. International Assets Investment Management LLC increased its position in Cameco by 3.1% during the third quarter. International Assets Investment Management LLC now owns 3,938 shares of the basic materials company’s stock worth $330,000 after buying an additional 120 shares in the last quarter. Lee Johnson Capital Management LLC boosted its stake in shares of Cameco by 1.2% during the third quarter. Lee Johnson Capital Management LLC now owns 10,770 shares of the basic materials company’s stock valued at $903,000 after acquiring an additional 127 shares during the last quarter. Wealth Alliance LLC boosted its stake in shares of Cameco by 1.6% during the second quarter. Wealth Alliance LLC now owns 10,036 shares of the basic materials company’s stock valued at $745,000 after acquiring an additional 154 shares during the last quarter. Versant Capital Management Inc increased its position in Cameco by 11.2% during the 3rd quarter. Versant Capital Management Inc now owns 1,590 shares of the basic materials company’s stock worth $133,000 after purchasing an additional 160 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its position in Cameco by 4.4% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 3,758 shares of the basic materials company’s stock worth $315,000 after purchasing an additional 160 shares in the last quarter. Institutional investors and hedge funds own 70.21% of the company’s stock.

More Cameco News

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: GLJ Research reiterated a buy rating on Cameco, supporting upside sentiment from some sell‑side firms that expect continued strength in uranium demand. GLJ Research Reiterates Buy for Cameco (NYSE:CCJ)
• Positive Sentiment: MarketBeat highlighted a bullish, longer-term case that global adoption of nuclear power could keep demand for uranium—and Cameco’s revenues—elevated, a thematic driver that has helped CCJ’s recent run. Can Cameco Continue Its Run?
• Neutral Sentiment: Scotiabank trimmed its FY2027 EPS forecast for Cameco slightly (from $1.53 to $1.48) but left an Outperform rating in place—this is a modest earnings haircut rather than a full-scale outlook change, so the impact may be limited unless revisions accelerate. MarketBeat: Cameco / Scotiabank Note
• Negative Sentiment: Zacks Research downgraded Cameco from “strong-buy” to “hold,” which can pressure momentum players and reduce near-term buying conviction. Zacks.com
• Negative Sentiment: There was unusually large put option activity—roughly 28,210 puts (about a 942% increase vs. average)—indicating elevated hedging or speculative bearish positioning that can amplify intraday volatility and signal downside risk if sentiment shifts. Investors Buy High Volume of Cameco Put Options

Cameco Price Performance

CCJ opened at $121.16 on Friday. Cameco Corporation has a 1 year low of $35.00 and a 1 year high of $135.24. The company’s 50 day simple moving average is $108.78 and its 200 day simple moving average is $93.26. The stock has a market capitalization of $52.77 billion, a PE ratio of 124.91 and a beta of 0.99. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.85 and a current ratio of 2.47.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its quarterly earnings results on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.29 by $0.07. The firm had revenue of $874.57 million during the quarter, compared to analyst estimates of $782.13 million. Cameco had a net margin of 17.00% and a return on equity of 9.35%. Cameco’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.36 earnings per share. As a group, sell-side analysts expect that Cameco Corporation will post 1.27 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CCJ. The Goldman Sachs Group restated a “buy” rating and issued a $131.00 target price on shares of Cameco in a report on Wednesday, February 4th. Zacks Research lowered shares of Cameco from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank Of Canada upped their price objective on shares of Cameco from $150.00 to $160.00 and gave the company an “outperform” rating in a research note on Tuesday. Raymond James Financial restated an “outperform” rating on shares of Cameco in a research report on Wednesday, January 14th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cameco in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $143.03.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.